SEC Filing Summary

Darren W. McDew, a director at Abbott Laboratories, was granted an award of 2,286 restricted stock units on April 24, 2026. This award, granted under the Abbott Laboratories 2026 Incentive Stock Program, will be settled in common shares on a one-to-one basis. The settlement will occur upon the director's separation from service, death, or a change in control. Following this transaction, McDew holds 12,678 shares. A power of attorney document was also filed, authorizing specific individuals to act on McDew's behalf for SEC filings related to Rule 144 and Section 16(a) of the Securities Exchange Act of 1934.